272 related articles for article (PubMed ID: 17543286)
21. Prepare cells to repair the heart: mesenchymal stem cells for the treatment of heart failure.
Ohnishi S; Nagaya N
Am J Nephrol; 2007; 27(3):301-7. PubMed ID: 17460394
[TBL] [Abstract][Full Text] [Related]
22. Life-sparing effect of human cord blood-mesenchymal stem cells in experimental acute kidney injury.
Morigi M; Rota C; Montemurro T; Montelatici E; Lo Cicero V; Imberti B; Abbate M; Zoja C; Cassis P; Longaretti L; Rebulla P; Introna M; Capelli C; Benigni A; Remuzzi G; Lazzari L
Stem Cells; 2010 Mar; 28(3):513-22. PubMed ID: 20049901
[TBL] [Abstract][Full Text] [Related]
23. Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation.
Reinders ME; Fibbe WE; Rabelink TJ
Nephrol Dial Transplant; 2010 Jan; 25(1):17-24. PubMed ID: 19861311
[TBL] [Abstract][Full Text] [Related]
24. Metabolic flexibility permits mesenchymal stem cell survival in an ischemic environment.
Mylotte LA; Duffy AM; Murphy M; O'Brien T; Samali A; Barry F; Szegezdi E
Stem Cells; 2008 May; 26(5):1325-36. PubMed ID: 18308942
[TBL] [Abstract][Full Text] [Related]
25. Bone regeneration with active angiogenesis by basic fibroblast growth factor gene transfected mesenchymal stem cells seeded on porous beta-TCP ceramic scaffolds.
Guo X; Zheng Q; Kulbatski I; Yuan Q; Yang S; Shao Z; Wang H; Xiao B; Pan Z; Tang S
Biomed Mater; 2006 Sep; 1(3):93-9. PubMed ID: 18458388
[TBL] [Abstract][Full Text] [Related]
26. Mesenchymal stem cells as trophic mediators.
Caplan AI; Dennis JE
J Cell Biochem; 2006 Aug; 98(5):1076-84. PubMed ID: 16619257
[TBL] [Abstract][Full Text] [Related]
27. Late-outgrowth endothelial cells attenuate intimal hyperplasia contributed by mesenchymal stem cells after vascular injury.
Wang CH; Cherng WJ; Yang NI; Kuo LT; Hsu CM; Yeh HI; Lan YJ; Yeh CH; Stanford WL
Arterioscler Thromb Vasc Biol; 2008 Jan; 28(1):54-60. PubMed ID: 17991877
[TBL] [Abstract][Full Text] [Related]
28. Impact of myocardial infarct proteins and oscillating pressure on the differentiation of mesenchymal stem cells: effect of acute myocardial infarction on stem cell differentiation.
Chang SA; Lee EJ; Kang HJ; Zhang SY; Kim JH; Li L; Youn SW; Lee CS; Kim KH; Won JY; Sohn JW; Park KW; Cho HJ; Yang SE; Oh WI; Yang YS; Ho WK; Park YB; Kim HS
Stem Cells; 2008 Jul; 26(7):1901-12. PubMed ID: 18403756
[TBL] [Abstract][Full Text] [Related]
29. Bone marrow-derived mesenchymal stem cells for treatment of heart failure: is it all paracrine actions and immunomodulation?
Mishra PK
J Cardiovasc Med (Hagerstown); 2008 Feb; 9(2):122-8. PubMed ID: 18192802
[TBL] [Abstract][Full Text] [Related]
30. From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells.
Giordano A; Galderisi U; Marino IR
J Cell Physiol; 2007 Apr; 211(1):27-35. PubMed ID: 17226788
[TBL] [Abstract][Full Text] [Related]
31. Emerging role for bone marrow derived mesenchymal stem cells in myocardial regenerative therapy.
Zimmet JM; Hare JM
Basic Res Cardiol; 2005 Nov; 100(6):471-81. PubMed ID: 16237508
[TBL] [Abstract][Full Text] [Related]
32. Role of tumor necrosis factor receptor 1 in sex differences of stem cell mediated cardioprotection.
Zeller CN; Wang Y; Markel TA; Weil B; Abarbanell A; Herrmann JL; Kelly ML; Coffey A; Meldrum DR
Ann Thorac Surg; 2009 Mar; 87(3):812-9. PubMed ID: 19231395
[TBL] [Abstract][Full Text] [Related]
33. Cell therapy for ischemic heart disease.
Bonaros N; Yang S; Ott H; Kocher A
Panminerva Med; 2004 Mar; 46(1):13-23. PubMed ID: 15238878
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of action of mesenchymal stem cells in cardiac repair: potential influences on the cardiac stem cell niche.
Mazhari R; Hare JM
Nat Clin Pract Cardiovasc Med; 2007 Feb; 4 Suppl 1():S21-6. PubMed ID: 17230212
[TBL] [Abstract][Full Text] [Related]
35. Mesenchymal stem cell therapy for degenerative inflammatory disorders.
Müller I; Lymperi S; Dazzi F
Curr Opin Organ Transplant; 2008 Dec; 13(6):639-44. PubMed ID: 19060556
[TBL] [Abstract][Full Text] [Related]
36. Immunological properties of mesenchymal stem cells and clinical implications.
Patel SA; Sherman L; Munoz J; Rameshwar P
Arch Immunol Ther Exp (Warsz); 2008; 56(1):1-8. PubMed ID: 18250975
[TBL] [Abstract][Full Text] [Related]
37. Human embryonic stem cell-derived vascular smooth muscle cells in therapeutic neovascularisation.
Cheung C; Sinha S
J Mol Cell Cardiol; 2011 Nov; 51(5):651-64. PubMed ID: 21816157
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of humoral response to allogeneic porcine mesenchymal stem cell with 12 days of tacrolimus.
Poncelet AJ; Nizet Y; Vercruysse J; Hiel AL; Saliez A; Gianello P
Transplantation; 2008 Dec; 86(11):1586-95. PubMed ID: 19077894
[TBL] [Abstract][Full Text] [Related]
39. Umbilical cord mesenchymal stem cells: adjuvants for human cell transplantation.
Friedman R; Betancur M; Boissel L; Tuncer H; Cetrulo C; Klingemann H
Biol Blood Marrow Transplant; 2007 Dec; 13(12):1477-86. PubMed ID: 18022578
[TBL] [Abstract][Full Text] [Related]
40. Increased proliferation of human synovial mesenchymal stem cells with autologous human serum: comparisons with bone marrow mesenchymal stem cells and with fetal bovine serum.
Nimura A; Muneta T; Koga H; Mochizuki T; Suzuki K; Makino H; Umezawa A; Sekiya I
Arthritis Rheum; 2008 Feb; 58(2):501-10. PubMed ID: 18240254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
